Calcium Antagonists and Renal Failure Progression
Author:
Publisher
Informa UK Limited
Subject
Nephrology,Critical Care and Intensive Care Medicine,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1080/08860220701856946
Reference110 articles.
1. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
2. Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
3. A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease
4. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
5. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New Insights into the Nephroprotective Potential of Lercanidipine;International Journal of Molecular Sciences;2023-09-13
2. Evidence-based appraisal of blood pressure reduction in spontaneous intracerebral hemorrhage: A scoping review and overview;Clinical Neurology and Neurosurgery;2021-03
3. Lercanidipine in the management of hypertension: An update;Journal of Pharmacology and Pharmacotherapeutics;2017
4. Can lercanidipine improve renal function in patients with atherosclerotic renal artery stenosis undergoing renal artery intervention?;Current Medical Research and Opinion;2014-11-26
5. Renal protection with calcium antagonists: the role of lercanidipine;Current Medical Research and Opinion;2013-09-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3